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We have described previously a transcription-dependent in- 
duction of glycogen resynthesis by the vasoactive intestinal 
peptide (VIP) or noradrenaline (NA) in astrocytes, which is 
mediated by CAMP. Because it has been postulated that the 
CAMP-mediated regulation of energy balance in hepatocytes 
and adipocytes is channeled at least in pat-t through the 
CCAAT/enhancer binding protein (CYEBP) family of transcrip- 
tion factors, we tested the hypothesis that CYEBP isoforms 
could be expressed in mouse cortical astrocytes and that their 
level of expression could be regulated by VIP, by the VIP- 
related neuropeptide pituitary adenylate cyclase-activating 
peptide (PACAP), or by NA. We report in this study that in these 
cells, CIEBPP and C/EBPG are induced by VIP, PACAP, or NA 
via the CAMP second-messenger pathway. Induction of 
C/EBPP and -6 mRNA by VIP occurs in the presence of a 
protein synthesis inhibitor. Thus, clebpp and clebp6 behave as 
CAMP-inducible immediate-early genes in astrocytes. More- 
over, transfection of astrocytes with expression vectors selec- 
tively producing the transcriptionally active form of CIEBPP, 
termed liver-enriched transcriptional activator protein, or 
CIEBPG enhance the glycogen resynthesis elicited by NA, 
whereas an expression vector producing the transcriptionally 
inactive form of C/EBPP, termed liver-enriched transcriptional 
inhibitory protein, reduces this resynthesis. These results sup- 
port the idea that CIEBPP and -6 regulate gene expression of 
energy metabolism-related enzymes in astrocytes. 
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There is increasing evidence that neurotransmitters exert 
receptor-mediated effects in astrocytes (Barres, 1991; Murphy, 
1993). In particular, we have demonstrated pronounced short- 
and long-term effects of the vasoactive intestinal peptide (VIP) 
and the monoamine noradrenaline (NA) on astrocyte glycogen 
metabolism (Sorg and Magistretti, 1991, 1992; Magistretti et al., 
1993). Thus, activation of VIP or NA receptors leads within 
minutes to glycogenolysis, followed within a few hours by a mas- 
sive glycogen resynthesis (Sorg and Magistretti, 1991, 1992). Gly- 
cogen is the single largest energy reserve of the brain. It is 
localized predominantly in astrocytes, to such an extent that this 
cell type can be positively identified at the ultrastructural level by 
the presence of glycogen granules in the cytoplasm (Peters et al., 
1991). Glycogen turnover in the nervous system is very rapid 
and is under the control of multiple regulatory mechanisms 
(Magistretti, 1988, 1990). Decreased synaptic activity that is 
achieved, for example, by anesthesia or slow-wave sleep markedly 
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increases the glycogen content of the brain. Pathological condi- 
tions leading to neuronal loss, such as brain trauma, x-ray irradi- 
ation, or Alzheimer’s disease, also cause a massive deposition of 
glycogen granules in the reactive astrocytes at the periphery of the 
lesioned areas [see Magistretti et al. (1993) and references there- 
in]. The modulation of brain glycogen levels by VIP or NA led us 
to propose that the primary action of certain neurotransmitters is 
to regulate local-energy homeostasis within the CNS by acting on 
non-neuronal cells such as astrocytes (Magistretti, 1990, 1991). 
The massive glycogen resynthesis elicited by VIP or NA in mouse 
cortical astrocytes is mediated by specific receptors coupled to the 
CAMP signal transduction cascade, and it is suppressed by cyclo- 
heximide or actinomycin D, which implies new protein synthesis 
(Sorg and Magistretti, 1992). 
In an attempt to characterize further this receptor-mediated 
translational-dependent event triggered by VIP or NA in a CAMP- 
dependent manner (Sorg and Magistretti, 1992), we focused our 
attention on a family of transcription factors called CCAAT/ 
enhancer-binding protein (C/EBP). Like the Fos/Jun and activat- 
ing transcription factor/CAMP-responsive element binding pro- 
tein (ATF/CREB) families, C/EBPs are characterized by a 
bipartite DNA-binding domain, composed of a basic region, con- 
tacting DNA, linked to a homo- or heterodimer-forming region 
called leucine zipper (for review, see Lamb and M&night, 1991; 
M&night, 1992). The first member of this family, C/EBPa, was 
found at high levels in adipose, hepatic, and placental tissues and 
at lower levels in lung and small intestine (Birkenmeier et al., 
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1989). Except for lung, each of these tissues can be considered to 
be part of the network of organs that facilitates the uptake, 
metabolism, and storage of physiological fuels. Therefore, it has 
been speculated that regulation of energy balance is channeled, at 
least in part, through C/EBPcv (McKnight et al., 198’)). The 
C/EBP family also includes C/EBP/3 (this is referred to in the 
literature also as NF-IM, IL-6-DBP, LAP, AGPIEBP, or CRP2), 
C/EBPS (also called CRP3, CELF, or NF-IL6/3), and CiEBPy 
(also known as Ig/EBP-I) (for review, see McKnight, 1992; Chcn- 
Kiang ct al., IYW). Members of the C/EBP family can form homo- 
or hcterodimers, all of which can bind to the same c&-regulatory 
elements. C/EBPa, -/3, and -6 arc involved in terminal diffcrcnti- 
ation of a variety of cells including adipocytcs, hepatocytcs, gut 
cpithelial cells, macrophages, and myelomonocytes (Friedman et 
al., lY89; Cao ct al., 1991; Natsuka et al., lY92; Scott et al., lYY2; 
Chandrasekaran and Gordon, 1003; Yeh et al., 199.5). Further- 
more, C/EBPp and -6 activate various genes involved in acutc- 
phase, inflammatory, and immune rcsponscs (Akira and Kishi- 
mote, 1992; Chen-Kiang et al., 1903) [: see also Tanaka et al. ( 1995) 
and references therein]. Thus, C/EBPs appear to be pleiotropic 
transactivators involved in tissue-specific metabolic gene tran- 
scription, in signal transduction activated by several cytokines, and 
in cell ditfcrcntiation. Because some C/EBP isoforms stimulate 
the expression of gcncs encoding for enzymes involved in cnergy- 
metabolism regulation and because C/EBPp and -6 have been 
shown to bc implicated in CAMP responsiveness (Kagcyama et al., 
IYYI; Mctz and Ziff, 1991; Park ct al., lYY3; Vallcjo ct al., lYY3), 
we tested the hypothesis that members of the CiEBP family are 
cxprcssed in astrocytes and that their level of expression is regu- 
lated by VIP, by the VIP-related neuropeptidc pituitary adcnylate 
cyclnsc-activating polypeptide (PACAP), or by NA. 
In this report, WC demonstrate that in mouse cortical astrocytes 
VIP, PACAP and NA increase C/EBPp and -6 isoforms at the 
mRNA and protein lcvcls via a CAMP-dependent mechanism. 
Induction of C/EBP/3 and -6 mRNA by VIP is rapid and occurs in 
the presence of a protein synthesis inhibitor. c/el~j~~ and ciebp6, 
therefore. can be considered to bc CAMP-inducible immediate- 
early genes in mouse astrocytcs. Moreover, overexpression of 
C/EBPS or liver-enriched transcriptional activator protein (LAP), 
the transcriptionally active form of CIEBPP, by transient trans- 
fection of astrocytes with expression vectors containing their 
cDNA sequence, showed that thcsc transcription factors can 
incrcasc NA-mediated glycogen resynthesis. This suggests that 
C/EBPp and -6 are primary target genes of the signal transduction 
pathway triggered by VIP, PACAP27, or NA, which regulate 
glycogcn metabolism in the brain. 
MATERIALS AND METHODS 
7rts~c~ crrlrltrr. Primary cultures of ccrcbrnl cortical astrocytcs were prc- 
pared from l- to 2-d-old Swiss albino mice as dcscribcd previously (Sorg 
and Magistrctti, I(%?). Briefly. forebrains were removed aseptically from 
the skulls, the meninges were excised carefully, and the ncocortcx was 
dissected free. The cells wcrc dissociated by passage through necdlcs of 
dccrcasing gauges (1.2 X 40, 0.8 X 40, and 0.5 X I6 mm) with a IO ml 
syringe. No trypsin was used for dissociation. The cells were seeded on 
poly-ornithine-co~lted dishes in Dulhccco’s modified Eagle’s medium 
(DMEM) containing 10% fetal calf serum and incubated at 37°C in an 
atmosphcrc containing 5%’ CO,/c)S% air. The culture medium was re- 
newed after 5 d of seeding and then twice per week. This procedure yields 
culture5 in which >9Oc/r of cells arc immunorcactivc for glial fibrillary 
acidic protein (GFAP) (Sorg and Magistretti, 1992). 
E~po.sur~ to tz(‘zfrotrutz.snzitt~r,s. During all incubations, primary cultures 
of astrocytes were maintained at 37°C in an atmosphcrc containing SC/r 
CO,/%% air. Twenty-four hours before treatment, the culture medium 
was rcmovcd and astrocytcs were incubated in serum-free DMEM. With- 
out changing the medium, the cells then were exposed to VIP. PACAP27. 
NA, or other phal-macological agents to attain the desired linal conccn- 
trations. When required, cells weI-e cxposcd for 30 min to the protein 
synthesis inhibitor anisomycin before VIP exposure. Similar-ly. the adrcn- 
crgic antagonists atcnolol and prazosin wcrc added to the cells IO min 
before NA treatment. At the end of the various pcrioda of incubation, 
cells were washed three times with ice-cold PBS, pH 7.4. and total KNA 
or protein was extracted. VIP and PACAP WCI-c purchased from 
Bnchem (Buhcndorf, Switzerland). and all other rcagcnts wcru purchased 
from Sigma (St. Louis, MO). 
Westcr-/7 ii?~?zcorohlor crtzcr!ysi.s. For Western immunoblot analyses. total 
proteins from astrocyter cultured in 35 mm dishes wcrc cxtractcd with SO 
~1 of lysis buffer [SO mM Tris-HCI. pH 6.8, IO0 IllM dithiothrcitol (DTT). 
0.3% SDS] and heated to 100°C for S min. Samples then were sonicatcd 
to shear gcnomic DNA, and a 2 ~1 aliquot was used to mcasurc the 
protein content following the method of Bradford ( 1970). Protein (50 pg) 
from each sample was adjusted to give a final hutt‘cr composition of 50 
nlM Tris-HCI, pH 6.X, 100 InM DIT, 2(4 SDS, O? glycerol. and 0. I (h 
bromophcnol blue, and was hcatcd to 100°C for 5 min. electrophoresed 
through a 12% SDS-polyacrylamidc gel, and transferred to nitroccllulosc 
membranes. CiEBP isoforms were detcctcd with the BM chcmilumines- 
cence detection system as rccommendcd by the manufacturer (Bochr- 
inger Mannheim, Mannheim. Germany). The dilution factor for each 
primary antibody was I:2000 for anli-C/EBPp and I:3000 for anti-C/ 
EBPG. Anti-C/EBPP was raised against the C-terminal IX amino acids 01 
C/EBP/3, whereas anti-CiEBPG was raised against the full-length protein. 
These antibodies were provided by S. L. McKnight (Tularik, South San 
Francisco, CA). For some cxpcrimcnts (hcc figure legends for details), 
CiEBPfi was dctcctcd with an affinity-purified rabbit polyclonal antibody 
(dilution l:SOO, Santa Cruz Biotechnology. Santa Crux. CA) raised 
against R pcptidc corresponding to the C-terminal 22 amino acida of rat 
CIEBPG. Both anti-CiEBP6 antibodics rccognizcd ;I regulated band. the 
M, of which corresponded to CIEBP6. The identity of the rcgulatcd bands 
dctcctcd by the anti-CiEBPfi or anti-CiEBPG antibodies was conlirmcd by 
the absence of immunoreactivity when the antibodies were prcabsorbed 
with the pcptidcs corresponding to the C-terminal IO or 23 amino acids 
of C/EBPp and -6, respectively. 
Nwt/wm /dot crmrl?:si.s. Total RNA was extracted using the c‘sc’l cen- 
trifugation procedure as described by Chirgwin ct al. ( 1070). Twenty 
micrograms of each RNA sample were clcctrophorcscd through dcm- 
turing 1.3% agarose gels containing 2 M formaldchydc, and wcrc trans- 
ferred to nylon memhranc (Gcnc Screen. DuPont NEN. Boston. MA). 
Hybridization was pcrformcd for at least I8 hr at 63°C in SO? formamide, 
Sk SSC, 250 mM.Tris-HCI, pH 75, O.S$; sodium pyrophosph;itc. 5”; 
SDS. 1% nolvvinvlnvrrolidonc. 19 Ficoll, 3.5 IllM EDTA. 1’;; bovine 
serum albu’mi;i, ani ‘150 pg/ml sheared denatured salmon sperm DNA, 
which contained an antisense “P riboprobc gcncrated cithcr from the 
full-length mouse CiEBPg cDNA or from an EcoRliXl~ol fragment of the 
mouse CIEBPG cDNA. Filters then were washed under high-stringency 
conditions (twice with 2~ SSCIO.1 % SDS at 05°C‘ for 15 min and twice 
with 0. I X SSCIO. I % SDS at 65°C for IS min), and ;lutor;idiogr;iphcd at 
-70°C with an intensifying screen. 
The lcvcls of C/EBPp or -6 mRNA wcrc dctcrmincd by scanning 
densitomctry (Biolmage system, Milliporc, Milford, MA) and normalized 
for dilfercnces in gel loading as compared with the Icvcls of p-actin 
mRNA. which were determined by rchybridization with an antiscnse 
p-actin “P riboprohc after stripping the filters. 
I~~~nz~rt~~~fl~torp.sc~~tzc~ utzu!ysis. Mouse cerebral cortical actrocytcs were 
grown to confluence on poly-ornithinc-coated 12 mm glass coverslips in 
24.well microtitcr dishes under the same conditions as described above. 
After 24 hr in serum-free DMEM, the cells wcrc stimulated with IO ’ M 
VIP for 4 hr. washed with ice-cold PBS, fixed with acctonc. and dried. 
They then were pcrmeabilizcd with 0.01% Triton X-100 in PBS. and the 
nonspecific sites were blocked with normal swine scl-um ( 1:2S. Dakopatts. 
Copenhagen, Denmark). Double labeling was performed by incubating 
cells overnight with a mouse monoclonal anti-GFAP antibody ( I:XOO. 
Boehringcr Mannheim) and atIinity-purified rabbit polyclonal anti-C/ 
EBPp or anti-CiEBPfi antibodies (IO &ml. Santa Crux Biotechnology). 
Anti-C/EBPP was raised against a peptidc corresponding to the 
C-terminal I9 amino acids of rat CIEBPP; anti-CiEBPfi was raised against 
a peptidc corresponding to the C-terminal 12 amino acids of rat C/EBPcS. 
The specificity of the anti-C/EBP antibodies was tcstcd by neutralization 
with a IO-fold (by weight) excess of each peptidc ( IO0 pg/ml, Santa Crtu 
Biotechnology). Blocking pcptides and antibodies were preincubatcd for 
2 hr bcforc being applied to the cells. After three washes with PBS. the 
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Fig~rp 1. Induction of the transcription factors C/EBPp and -S by VIP in cultures of mouse cortical astrocytes. A, Cultures of cortical astrocytes were 
incubated for various periods of time (indicated on top of each lane) in the presence of IO-’ M VIP. For CIEBPS, control cultures incubated in the absence 
of VIP (p) were performed at each point of the time course. Equal amounts of total protein extracts (50 fig) were analyzed by 12% SDS-PAGE, and 
CiEBPp or CIEBPG were detected by Western immunoblot analysis. Protein M, markers are indicated (in kDa) to the left of the panels. Bands 
corresponding to CiEBPp or -S arc indicated by arrow.~ at the right. CiEBP-unrelated cross-reacting material (crm) (Cao et al., IYYI) served as a loading 
control. B, Etfect of increasing concentrations of VIP on the expression of CIEBPf3 and -6. Proteins were collected after a 4 hr stimulation in the presence 
of the indicated concentration of VIP and were analyzed as described in A. Similar results were obtained in at least three independent experiments. 
cells were layered with rhodamine-conjugated sheep anti-mouse IgG 
(l:lO, Boehringer Mannheim) and fuorescein-conjugated swine anti- 
rabbit IgG (1:50, Dakopatts) in PBS at room temperature for 20 min. 
Finally, the coverslips were wa5hcd three times with PBS and mounted, 
and the cells were examined by fluoromicroscopy. 
Cell transfectmz and glycogen nssay. The CiEBP protein expression 
vector Moloney murine sarcoma virus (MSV)-C/EBPP and MSV-CIEBPG 
(for description, see Cao et al., 1991) were provided by S. L. McKnight 
(Tularik). The plasmid MSV-no insert was comtructed by deleting the 
UEBPS insert of MSV-CIEBPG. MSV-LAP and MSV-liver-enriched 
transcriptional inhibitory protein (LIP) were constructed by PCR follow- 
ing the strategy and using the primers described in Ych et al. (1995). 
5’-Primers were used to introduce an optimal Kozak consensus sequence 
and an EcoRl restriction site upstream from the second or third in-frame 
ATG, respecttvely, in the CiEBPP-coding sequence. The common down- 
stream primer contained a BamHl site for cloning into the MSV-long 
terminal repeat expression vector. PCR condrtions for generating recom- 
binant sequences from MSV-C/EBPP were as follows: one cycle at 94°C 
for 5 min, annealing at 52°C for 2 mm, extemion at 72°C for If) min, and 
then denaturation at 94°C for 1 min; annealing at 52°C for 2 min, 
extension at 72°C for 3 min, repeated for 34 cycles. Pwo DNA polymerase 
(Boehringer Mannheim) was used instead of Taq DNA polymerase to 
minimize the risk of errors during PCR. Reaction conditions were as 
recommended by Boehringer Mannheim, except that the amplification 
reactions also included 10% (v/v) dimethylsulfoxide. The amplified LAP 
and LIP cDNA fragments then were inserted to cloning sites of EcoRl 
and BanzHl into the MSV vector. 
Transient transfection of confluent mouse cortical astrocytes was 
performed using the liposome-mediated gene-transfer method with 
the cationic lipid N-1 I-(2,3-Dioleoyloxy)propyl]-N,N,N-trimethyl- 
ammoniummethylsulfate (DOTAP) according to the manufacturer’s in- 
structions (Boehringer Mannheim). A total of 5 kg of expression vector 
was transfected per 35 mm dish with a DOTAP concentration of 13.4 
kg/ml in serum-free DMEM. Cells were maintained for 7 hr in this 
medium before replacing it with DMEM containing 10% fetal calf serum 
and incubating further for 61 hr. Culture medium was replaced with a 
serum-free DMEM containing 5 tIIM glucose (instead of 25 mM for the 
culture medium). Four hours later, NA was added to the medium to a 
final concentration of 10- ’ M, and cultures were maintained for 6 hr in 
the incubator. The reaction then was stopped by washing the cells three 
times with ice-cold PBS and by adding either 1.5 ml of 30 mM HCI for the 
glycogen assay or 50 ~1 of lysis buffer for Western immunoblot analysis. 
For the glycogen assay, the cells were sonicated and the suspension was 
used to measure glycogen as described previously by Sorg and Magistretti 
(1992). Briefly, three 100 ~1 aliquots were sampled. In the first aliquot, 
300 ~1 of acetate buffer was added. In the second aliquot, 300 ~1 of a 
solution containing 10% amyloglucosidase (10 mgiml) in 0.1 M acetate 
buffer, pH 4.65, was added, and the mixture was incubated at room 
temperature for 30 min. After incubation with amyloglucosidase, 2 ml of 
0.1 M Tris-HCI buffer, pH 8.1, containing 3.3 mM MgCI,, 0.2 mM ATP, 25 
&ml nicotinamide adenine dinucleotide phosphate (NADP), 4 kg/ml, 
hexokinase, and 2 kg/ml glucose-6-phosphate dehydrogenase was added, 
and the mixture was incubated at room temperature for 30 min. The first 
aliquot was treated identically. The fluorescence of the NADPH formed 
then was read on a fluorometer (excitation, 340 nm; emission, 450 nm). 
The first aliquot gave the sum of glucose and glucose-h-phosphate, and 
the second gave the sum of glycogen, glucose, and glucose-h-phosphate; 
the amount of glycogen then was determined by the difference between 
the first two aliquots. The third aliquot was used to measure the protein 
content following the method of Bradford (1976). We should note that in 
this report, 1 mole of glycogen corresponds to I mole of glycosyl units 
originating from glycogen. ATP, NADP, and the enzymes were purchased 
from Boehringer Mannheim. Statistical analyses were performed by 
ANOVA followed by Dunnett’s test. 
RESULTS 
C/EBPp and -6 are induced by VIP in mouse 
cortical astrocytes 
To determine whether members of the C/EBP family were in- 
duced or modulated after exposure of mouse cortical astrocytes to 
VIP, we performed Western immunoblot analyses with antibodies 
against the well characterized CIEBP~U, -/3, and -6 isoforms. Al- 
though C/EBPa was not detected, either by Western immunoblot 
or by Northern blot (data not shown), we observed that the 
C/EBPp and -6 isoforms were induced in a time-dependent man- 
ner by lo-’ M VIP (Fig. 1A). The antibody against C/EBPP 
recognized two proteins with M, of 39 and 36 kDa; these proteins, 
which have been shown to be synthesized from C/EBPp mRNA, 
correspond to translation products initiated at the first and second 
in-frame AUGs of the CIEBPP mRNA; the initiation at the first 
in-frame AUG is less efficient than at the second in-frame AUG 
(Descombes and Schibler, 1991). An increase in C/EBPP protein 
levels occurred 2 hr after VIP exposure, reached a peak level 
between 4 and 8 hr, and began to decrease 12 hr after the onset 
of treatment (Fig. L4). Analysis of the time course of the induc- 
tion of CIEBPG showed that, unlike CIEBPP, an increase in 
C/EBPS can be observed only 30 min after VIP exposure. C/EBPS 
reached a maximal level after 4 hr, and unlike CIEBPP, still 
remained stable at high levels of expression 24 hr after exposure 
to VIP. Because basal levels of CIEBPS were higher than those of 
C/EBPp and appeared to be sensitive to conditions of stress, such 
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as medium renewal, we performed a control manipulation (i.e., 
same processing of the astrocytes without adding VIP) at each 
point of the time course. As indicated in Figure lB, VIP induced 
C/EBP/3 and -6 expression in a concentration-dependent manner, 
between lo-’ and 10ph M. 
To confirm that the induction of C/EBPP and -6 proteins 
actually was caused by an increase in their mRNA, we analyzed by 
Northern blotting total RNA extracted from astrocytes exposed to 
IO-’ M VIP for various periods of time (Fig. 24). These results 
confirmed the induction of C/EBP/3 and -6 at the mRNA level. As 
expected, the variations in mRNA levels preceded the variations 
in C/EBPp or -6 protein levels. C/EBPp mRNA levels increased 
already 30 min after VIP exposure, reached a peak between 2 and 
4 hr, and decreased 8 hr after the onset of treatment. C/EBPS 
mRNA levels increased gradually over time, stabilized at 4 hr, and 
remained maximally induced until at least 24 hr after addition of 
VIP (Fig. 248). The increase in C/EBPS mRNA 1.5 and 30 min 
after VIP exposure was weaker than the increase in CYEBPS 
protein at 30 min. This apparent inconsistency might be explained 
by the fact that a single mRNA molecule can be translated several 
times, thus providing an amplified signal at the protein level. 
Taken together, these results demonstrate that in mouse cortical 
astrocytes, VIP induces C/EBPp and -6 at the mRNA and protein 
levels in a time- and concentration-dependent manner. 
C/EBPP and -6 are induced by VIP as 
immediate-early genes 
Because C/EBPp and -6 arc transcription factors induced rela- 
tively rapidly by VIP, we wondered whether these two CIEBP 
isoforms were immediate-early response genes activated directly 
by constitutively expressed transcription factors. An immediate- 
early gene is defined as a gene that can be induced without & 
nova protein synthesis and, therefore, is not blocked by inhibitors 
of protein synthesis (for review, see Herschman, 1991). We there- 
fore exposed mouse cortical astrocytes to the protein synthesis 
inhibitor anisomycin at 20 PM for 30 min before VIP exposure, 
extracting total RNA 2 hr later (Fig. 3). In these conditions, 
protein synthesis was abolished almost completely (see legend of 
Fig. 3). Results indicated that C/EBPp and -6 mRNA production 
still was enhanced by VIP in the presence of anisomycin, suggest- 
ing that VIP induces ciebpp and c/ebpS gene transcription via a 
protein synthesis-independent mechanism. 
Treatment of astrocytes with anisomycin alone produced an 
induction of the C/EBPp and -6 mRNAs (Fig. 3). This phenom- 
enon, called superinduction, has been described previously and is 
thought to reflect the loss of labile transcriptional repressors or 
mRNA-degrading enzymes and, in general, is believed to be a 
direct consequence of the inhibition of protein synthesis. Inde- 
pendent of its ability to block translation, anisomycin also causes 
side effects, by intrinsically initiating intracellular signals and 
immediate-early gene induction (Cano et al., 1994). Regardless of 
the process that caused the superinduction of CIEBPS mRNA, we 
concluded from these experiments that the induction of c/ebp/? 
and clebpd gene transcription did not require new protein synthe- 
sis and, therefore, defined clebpj3 and c/ebpS as immediate-early 
genes in mouse cortical astrocytes. 
C/EBPP and -6 are localized in the nucleus of 
GFAP-positive cells 
The primary cultures of astrocytes used in this study contain >90% 
of cells immunoreactive for the astrocytic marker GFAP. The re- 
maining 10% is composed of progenitor cells for oligodendrocytes, 
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Figure 2. Induction of C/EBPp and -8 mRNA expression by VIP in 
cultures of mouse cortical astrocytes. A, Time course of CiEBPp and -S 
mRNA accumulation after exposure of cultures of cortical astrocytes to 
10 ’ M VIP. Equal amounts of total RNA (20 pg) were electrophoresed 
and analyzed by Northern blotting using ‘*P riboprobes complementary to 
C/EBPp or -6 mRNAs. Similar results were obtained in three independent 
experiments. RNA markers are indicated (in kb) at the /ej. Blots were 
hybridized sequentially with C/EBP and p-actin probes; the latter was used 
as a loading control. B, Results in A were quantified by scanning densi- 
tometry and are expressed as mean 5 SEM (n = 3) compared with the 
maximal level of expression for each C/EBP mRNA. 
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Figure 3. Induction of CiEBPp and -6 mRNA expression by VIP is not blocked by the protein synthesis inhibitor anisomycin. A, Cultures of cortical 
astrocytes were treated with the protein synthesis inhibitor anisomycin (Anise.; 2 X lo-’ M) 30 min before VIP (lo-’ M) addition, and then they were 
incubated for another 2 hr: Anisomycin at this concentration caused a 97 IT 7% (n = 3) reduction in the incorporation of [“Slmethionine into total protein 
during the 2 hr of VIP exposure. Equal amounts of total RNA (20 pg) were electrophoresed and analyzed by Northern blotting. Similar results were 
obtained in three independent experiments. The blots were hybridized sequentially with 32P riboprobes complementary to C/EBPfi, C/EBPS, and p-actin 
mRNAs; the latter was used as a loading control. B, Results in A were quantified by scanning densitometry and are expressed as the mean ? SEM 
(n = 3) compared with the C/EBP mRNA levels evoked by VIP in the absence of anisomycin. 
astrocytes, and microglia. It was necessary, therefore, to confirm that 
C/EBPP and -6 indeed were expressed by GFAP-positive cells. To do 
this, we performed double-immunofluorescence labeling of GFAP 
and C/EBP/l or GFAP and C/EBPS (Fig. 4). These results clearly 
showed that C/EBP/3 and -6 are expressed and localized in the 
nucleus of mouse cortical astrocytes exposed to VIP. The use of 
neutralizing peptides corresponding to the C-terminal part of 
C/EBPP or -S demonstrated the specificity of the antibodies against 
the C/EBP isoforms. In rat pheochromocytoma (PC)-12 cells, a 
translocation of CIEBPP from the cytoplasm to the nucleus after 
CAMP stimulation was described by Metz and Ziff (1991). Because 
the basal levels of C/EBP/3 were barely detectable, we did not 
observe such a translocation in mouse cortical astrocytes after expo- 
sure to VIP. The basal levels of C/EBPS were higher, with the protein 
specifically immunolocalized in the nucleus and not detected in the 
cytoplasm. 
PACAP induces C/EBPp and -6 in mouse 
cortical astrocytes 
A major action of VIP in the cerebral cortex is the stimulation of 
CAMP formation (Magistretti and Schorderet, 1984); therefore, 
we addressed the question of whether the VIP-related neuropep- 
tide PACAP also induced C/EBPP or -6, because PACAP stim- 
ulates CAMP formation more potently than VIP in rat primary 
astrocytes (Hashimoto et al., 1993). Two forms of PACAP, 
PACAP and PACAP27, have been identified and demonstrated 
to be equally potent in stimulating the adenylate cyclase (for 
review, see Arimura, 1992). We applied PACAP to mouse 
cortical astrocytes and found that it induced CIEBPP and -6 
expression in a concentration-dependent manner between lo-’ 
and lo-’ M (Fig. 5B). PACAP27, therefore, is lo-fold more potent 
than VIP in stimulating C/EBPP and -6 expression. However, 
some differences in the time course of C/EBPS induction by 
PACAP were observed compared with the time course of 
C/EBPS induction by VIP. Thus, C/EBPS protein levels increased 
only 4 hr after PACAP exposure and returned to the basal level 
24 hr after PACAP exposure (Fig. 54). Therefore, unlike VIP, 
PACAP induced C/EBP/? and -6 with a similar time course. 
NA induces CYEBPP and -6 in mouse 
cortical astrocytes 
Given the effects of VIP or the monoamine neurotransmitter NA 
on the energy metabolism of mouse astrocytes, as well as the 
capacity of NA to stimulate adenylate cyclase, we tested whether 
NA could induce C/EBPP or -6 isoforms. When NA was applied 
to mouse cortical astrocytes, we observed by Western immunoblot 
analysis the most rapid and persistent induction of C/EBPp and -6 
protein levels among the three neurotransmitters tested (Fig. 6,4). 
These levels still remained high 24 hr after NA exposure, although 
C/EBPP levels were lower than the maximal induction observed 
at 4 hr. Furthermore, NA induced CIEBPP and -6 in a 
concentration-dependent manner, with an effect already apparent 
at lo-’ M (Fig. 6B). This induction could be mimicked by the 
/3-adrenergic receptor agonist isoproterenol, but not by the (Y,- 
agonist methoxamine (Fig. 6C). Moreover, the NA-mediated 
C/EBPP and -6 induction was decreased by the /31-adrenergic 
receptor antagonist atenolol, but not by the a,-antagonist prazo- 
sin. Taken together, these pharmacological analyses trongly sug- 
gest that NA induces C/EBPP and -6 via receptors of the 
p-subtype that are coupled to adenylate cyclase (for review, see 
Summers and McMartin, 1993). 
8-(CBromo)-CAMP and forskolin induce C/EBP/3 and 
-6 in mouse cortical astrocytes 
The foregoing results provided a strong indication that VIP, 
PACAP27, and NA likely induce CIEBPP and -6 by increasing 
intracellular CAMP levels in mouse cortical astrocytes. This was 
confirmed further by the observation that the CAMP analog 8-(4- 
bromo)-CAMP [8-(4Br)-CAMP] and the direct adenylate cyclase 
activator forskolin also induced CIEBPP and -6 (Fig. 7). The 
kinetics of the induction of C/EBPP and -6 by 8-(4Br)-CAMP or 
forskolin was similar to that observed with VIP, PACAP27, or 
Figuve 4. Immunohistochemical localization of C/EBPp and -6 in the nucleus of GFAP-positive cells. Cultures of mouse cortical astrocytes exposed to 
VIP (lo-’ M) for 4 hr were fixed with acetone, and double-immunofluorescence microscopy was performed using antibodies against C/EBPp and GFAP 
(A-D) or CiEBP8 and GFAP (E-H). A, Fluorescein staining of CIEBPP. B, Rhodamine staining of the astrocytic marker GFAP and fluorescein staining 
of C/EBPP within the field shown in A. CLEBPP is localized in the nucleus of the GFAP-positive cells. C, Control for nonspecific fluorescein labeling with 
the antibody against C/EBPP. Neutralization of anti-C/EBPP antibody with the peptide against which it has been raised caused a total loss of nuclear 
staining. D, Control of the anti-C/EBPP antibody specificity. Preincubation of the antibody against C/EBPP with the peptide corresponding to C/EBPG 
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Figure 5. Induction of CIEBPP and -8 by PACAP in cultures of mouse cortical astrocytes. A, Cultures of cortical astrocytes were incubated for various 
periods of time (indicated at the top of each lane) in the presence of 10-s M PACAP27. Equal amounts of total protein extracts (50 pg) were analyzed 
by 12% SDS-PAGE, and C/EBPP or -8 were detected by Western immunoblot analysis. Bands corresponding to C/EBP/3 or -6 are indicated by arrows 
at the right. C/EBP-unrelated cross-reacting material (cmz) (Cao et al., 1991) served as a loading control. B, Effect of PACAP at increasing 
concentrations on the expression of CIEBPP and -6. Proteins were collected after a 4 hr stimulation in the presence of the indicated concentration of 
PACAP and were analyzed as described in A. Similar results were obtained in three independent experiments. 
NA. Thus, clebpp and clebp6 can be considered to be CAMP- 
responsive immediate-early genes in mouse cortical astrocytes. 
PACAP and NA induce CIEBPP and -6 mRNA in 
mouse cortical astrocytes 
To confirm that the induction of C/EBPP and -6 by PACAP or 
NA was caused by an increase in their mRNA, we analyzed by 
Northern blotting total RNA extracted from astrocytes exposed 
for 2 hr to these two neurotransmitters. As shown in Figure 8, 
lo-’ M PACAP or lo-’ M NA induces C/EBPP and -6 mRNAs 
to a similar extent as IO-’ M VIP. 
Involvement of CYEBPS and LAP in 
glycogen resynthesis 
Because we demonstrated that the /3 and S isoforms of the C/EBP 
family of transcription factors were induced rapidly by VIP, 
PACAP27, or NA in mouse cultured cortical astrocytes, we con- 
sidered the possibility that these factors mediate the CAMP- and 
protein synthesis-dependent resynthesis of glycogen elicited by 
VIP or NA in these cells (Sorg and Magistretti, 1992). To test this 
hypothesis, we first attempted to overexpress C/EBPP or -6 by 
transfecting astrocytes with expression vectors containing their 
cDNA. We monitored the expression of the C/EBP isoforms by 
Western immunoblotting. Although C/EBPS was overexpressed 
efficiently, C/EBPP was expressed only poorly (data not shown). 
The failure to overexpress C/EBPP likely was attributable to an 
inefficient initiation of translation, because the C/J3BP/3 mRNA 
can be translated from three in-frame AUGs to yield three pro- 
teins called LAP*, LAP, and LIP (Descombes and Schibler, 1991). 
Therefore, we decided to construct the MSV-LAP and MSV-LIP 
expression vectors as described by Yeh et al. (1995). The intro- 
duction of an optimal Kozak consensus equence upstream from 
the second or third in-frame AUG allowed the selective overex- 
pression of the transcriptionally active form of C/EBPP, termed 
LAP, or the transcriptionally inactive form of CIEBPP, termed 
LIP, respectively. Although LAP and C/EBPS were expressed at 
high levels after the transfection of astrocytes, glycogen levels 
were not enhanced significantly (data not shown). Of interest, 
however, overexpression of LIP reduced glycogen levels signifi- 
cantly, which were 18.2 2 0.9 nmol of glycogen/mg of protein for 
the astrocytes transfected with MSV-no insert and 11.2 t 2.8 
nmol of glycogen/mg of protein for the astrocytes transfected with 
MSV-LIP, which suggests that glycogen synthesis was inhibited by 
the LIP-mediated inhibition of C/EBP isoforms. One possible 
explanation for the inefficiency of LAP and C/EBPG to increase 
glycogen levels is that a physiological response implying new 
protein synthesis, such as the resynthesis of glycogen in astrocytes, 
rarely is controlled by a single transcription factor. Tissue-specific 
gene transcription depends on a combination of &acting ele- 
ments, which are recognized by several transcription factors that, 
by binding simultaneously to the gene promoter, favor the forma- 
tion of the transcription initiation complex and the subsequent 
RNA synthesis by the RNA polymerase II. Therefore, if resyn- 
thesis of glycogen elicited by VIP or NA requires the induction of 
several transcription factors, then the overexpression of only one 
of these transcription factors would not be sufficient to increase 
glycogen levels. Because of this, we decided to transfect astrocytes 
with the expression vectors and then, after a period sufficient to 
overexpress LAP, LIP, or C/EBPG, expose the transfected astro- 
cytes to NA. The rationale for this protocol was that because 
glycogen resynthesis is a transcriptionally regulated CAMP- 
dependent phenomenon (Sorg and Magistretti, 1992), increases in 
CAMP levels triggered by NA could induce or activate other 
did not cause a loss of immunoreactivity in the nucleus of GFAP-positive cells. E, Fluorescein staining of C/EBPS. F, Rhodamine staining of the astrocytic 
marker GFAP and fluorescein staining of C/EBPG within the field shown in E. C/EBPS is localized in the nucleus of the GFAP-positive cells. G, Control 
of the anti-C/EBPG antibody specificity. Preincubation of the antibody against C/EBPG with the peptide corresponding to CiEBPp did not cause a loss 
of immunoreactivity in the nucleus of GFAP-positive cells. H, Control for nonspecific fluorescein labeling with the antibody against C/EBPG. 
Neutralization of anti-C/EBPG antibody with the peptide against which it has been raised caused a total loss of nuclear staining. Scale bar, 50 pm. 
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Figure 6. Induction of C/EBPp and -6 by NA in cultures of mouse cortical astrocytes is mediated by receptors of the P-subtype. A, Cultures of cortical 
astrocytes were incubated for various periods of time (indicated at the fop of each lane) in the presence of lo-’ M NA. Equal amounts of total protein 
extracts (50 Fg) were analyzed by 12% SDS-PAGE, and C/EBPp or -6 were detected by Western immunoblot analysis. Bands corresponding to C/EBPP 
or -6 are indicated by arrows at the right. Q’EBP-unrelated cross-reacting material (crm) (Cao et al., 1991) served as a loading control. B, Effect of NA 
concentration on the expression of C/EBP/3 and -6. Proteins were collected after a 4 hr stimulation in the presence of the indicated concentration of NA 
and were analyzed as described in A. C, Pharmacological characterization of the induction of CiEBPP and -8 by NA. Proteins were collected after a 4 
hr stimulation in the presence of the /3-adrenergic agonist isoproterenol (improt.) or the cY,-adrenergic agonist methoxamine (methox.) at concentrations 
indicated at the top of each lane (panels on the leff). The adrenergic receptor subtype implicated in the CiEBP/3 and -6 induction by NA was confirmed 
further by exposing the cells for 10 min to the p,-adrenergic antagonist atenolol (10d5 M) or to the cr,-adrenergic antagonist prazosin (lo-’ M) before 
the addition of NA ( 10eh M; panels on the tight). Western immunoblotting was performed as described in A. Similar results were obtained in at least three 
independent experiments. 
transcription factors that could synergize with the overexpressed 
LAP or C/EBPG to stimulate glycogen resynthesis maximally. 
Moreover, we decided to expose transfected astrocytes to NA for 
6 hr to measure glycogen levels when the rate of resynthesis is 
high (Sorg and Magistretti, 1992). A set of cultures was used to 
determine glycogen levels (Fig. 9A), and another set was used to 
monitor the overexpression of LAP, LIP, or C/EBPG by Western 
immunoblot analysis (Fig. 9B). Although the observed increase 
over basal glycogen levels was not proportional to the LAP or 
C/EBPS level, the overexpression of LAP or C/EBPS significantly 
and reproducibly increased the NA-induced glycogen resynthesis 
of the transfected astrocytes compared with astrocytes transfected 
with the control vector. Moreover, the overexpression of LIP 
reduced the NA-induced glycogen resynthesis. These results sug- 
gest that C/EBPG and the transcriptionally active form of CiEBPp 
play a role in the glycogen resynthesis triggered by NA. 
DISCUSSION 
Results reported in the present study indicate that in mouse 
primary cortical astrocytes the level of expression of the transcrip- 
tion factors C/EBPP and -6 is regulated by the neurotransmitters 
VIP, PACAP27, or NA, which stimulate the accumulation of 
CAMP in these cells. C/EBPP and -8 are induced by a CAMP- 
dependent mechanism, because the CAMP analog 8-(4Br)-CAMP 
and the adenylate cyclase activator forskolin also increase these 
C/EBP isoforms. c/ebp/3 and c/ebp6 can be considered to be 
CAMP-inducible immediate-early genes in mouse astrocytes, be- 
cause their induction by VIP still occurs in the presence of the 
8-(4Br)-CAMP 5 x lOA M 
Figure 7. Induction of C/EBPP or -6 expression via the CAMP second-messenger pathway. Proteins were collected after a 4 hr stimulation in the presence 
of the CAMP analog g-(4Br)-CAMP at 5 X 10m4 M or the adenylate cyclase activator forskolin at 5 X lo-’ M. Equal amounts of total protein extracts (50 
pg) were analyzed by 12% SDS-PAGE, and C/EBPp or -8 were detected by Western immunoblot analysis. In this experiment, CIEBPG was detected with 
an affinity-purified rabbit polyclonal antibody (1:500, Santa Cruz Biotechnology). Bands corresponding to C/EBPp or -8 are indicated by nrrows at the 
right. C/EBPP-unrelated cross-reacting material (crm) (Cao et al., 1991) served as a loading control. Similar results were obtained in at least three 
independent experiments. 
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Figure 8. Comparison of the induction of CIEBPB and -8 mRNA 2 hr after exposure to VIP, PACAP27, or NA.A, Cultures of cortical astrocytes were 
exposed for 2 hr to VIP (lo-’ M), PACAP (10-s M), or NA (lo-’ M). Equal amounts of total RNA (20 pg) were electrophoresed and analyzed by 
Northern blotting. Similar results were obtained in three independent experiments. The blots were hybridized sequentially with “P riboprobes 
complementary to CIEBPP, C/EBPG, and p-actin mRNAs; the latter was used as a loading control. B, Results in A were quantified by scanning 
densitometry and are expressed as mean 2 SEM (n = 3) compared with UEBP mRNA levels evoked by VIP. 
protein synthesis inhibitor anisomycin. Moreover, this study pro- 
vides evidence for a role of C/EBPP and -6 in the glycogen 
resynthesis elicited by VIP or NA. This suggests that c/ebp/3 and 
c/ebp6 are the primary target genes of VIP or NA and that these 
C/EBP isoforms then activate late genes, encoding for enzymes 
implicated in glycogen synthesis. If this hypothesis is true, the 
induction of C/EBP isoforms by VIP or NA would represent an 
intermediate step between the CAMP-dependent short-term (Sorg 
A 
4LIP 
I 4 CEBPG 
Figure 9. Effect of the transfection of mouse cortical astrocytes with LAP, LIP, or CiEBPS expression vectors on NA-mediated glycogen resynthesis. 
Cultures of cortical astrocytes were transfected transiently using the cationic lipid DOTAP with the MSV-no insert control plasmid (no insert) or with 
MSV-LAP, MSV-LIP, or MSV-CEBPS expression vectors. Three days after transfection, astrocytes were incubated in the presence of IO-’ M NA, and 
glycogen levels were assayed 6 hr later. A, Results are expressed as the percent glycogen level in astrocytes transfected with the MSV-no insert control 
plasmid, which was 347.6 i: 9.7 nmol of glycogemmg of protein. Results are expressed as mean + SEM of six separate determinations from two 
experiments, repeated twice with similar results. Asterisks indicate significant difference from MSV-no insert by ANOVA followed by Dunnett’s test (p 
< 0.01). The error bar at the leff represents SEM of MSV-no insert. B, Western blot monitoring the expression of LAP, LIP, or UEBPS in astrocytes 
transiently transfected with MSV-no insert, MSV-LAP, MSV-LIP, or MSV-UEBPS. Parallel astrocyte cultures treated as in A were analyzed by Western 
immunoblot to detect C/EBPP (LAP or LIP) and CIEBPG isoforms. Equal amounts of total protein extracts (50 pg) were separated by 12% SDS-PAGE. 
The bands identified as LAP’ and UP correspond to the proteins of 39 and 36 kDa, respectively, designated C/EBPp in the other figures. CIEBPG was 
detected with an affinity-purified rabbit polyclonal antibody (1:500, Santa Cruz Biotechnology). Note that the chemiluminescent blots were exposed for 
a brief period to avoid saturation of the signal for the overexpressed LAP, LIP, and CiEBPS. Consequently, the signal of C/EBPP and -6 was reduced 
considerably in the other lanes. 
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and Magistretti, 3991) and long-term (Sorg and Magistretti, 1992) 
effects of both neurotransmitters on glycogen metabolism. 
This study demonstrates a regulation of C/EBP transcription 
factors by neurotransmitters in cells of the vertebrate CNS. The 
presence of C/EBP isoforms in the mammalian brain has not been 
established clearly. Northern blot analysis of total RNA from 
mouse brain failed to reveal the presence of C/EBPo, $3, or -6 
mRNA (Cao et al., 1991) whereas in situ hybridization experi- 
ments localized C/EBPa mRNA in adult mouse brain, where it 
was concentrated primarily in the hippocampus, cerebellar Pur- 
kinje cells, and layers II and III of the cortex (Kuo et al., 1990). 
Such analysis has not been performed for C/EBP/3 or -6 mRNAs. 
However, the human homolog of C/EBPp has been identified in 
a glioblastoma cell line (Akira et al., 1990). Directly relevant to 
the present study is the report by Kageyama et al. (1991) who, 
while attempting to clone rat brain cDNAs on the basis of their 
ability to bind the CAMP-responsive element (CRE) of the sub- 
stance P and K precursor gene promoter, cloned in fact the rat 
homolog of CIEBPS, which they termed C/EBP-like factor (or 
CELF). In this latter study, C/EBPS mRNA could be detected in 
rat whole brain by Northern blot analysis performed with polyA+ 
RNA. C/EBPp is regulated by the CAMP second-messenger path- 
way also in the rat PC12 cell line (Metz and Ziff, 1991). The 
activity, as well as the expression, of C/EBP family members is 
also regulated by CAMP. Thus, the CAMP-stimulated phosphory- 
lation of C/EBPp is associated with its translocation to the nu- 
cleus, in which it can induce transcription of the cellular proto- 
oncogenc c-fos via interactions with the c-fos serum response 
element. A c/&y gene was shown recently to be activated by 
stimulation of serotonin receptors, which are coupled to the 
CAMP pathway in sensory neurons of the marine snail Aplysia 
(Alberini et al., 1994) (for review, see Stevens and Verma, 1994). 
Serotonin, a neurotransmitter released from neurons involved in 
a simple form of learning called sensitization, rapidly induced 
Aplysia C/EBP (ApC/EBP), even in the presence of protein syn- 
thesis inhibitors. Moreover, ApC/EBP plays a crucial role in the 
consolidation of stable, long-term synaptic plasticity in Aplysia. 
The induction of C/EBPp and -6 by VIP, PACAP27, or NA in 
mouse cortical astrocytes reported in this study shares a number 
of similarities with the induction of ApC/EBP by serotonin in 
Aplysio sensory neurons. Thus, ApCiEBP mRNA is induced by 
8-(4Br)-CAMP or forskolin, and its induction by serotonin is not 
blocked by anisomycin (Alberini et al., 1994). It is of interest that 
regulatory mechanisms of C/EBP family members have been 
conserved during evolution from neurons in a simple organism 
like Aplysiu to glial cells in a mammalian brain. 
In this study, we also show that the overexpression of CIEBPS 
and LAP significantly increases the NA-induced glycogen accu- 
mulation of transfccted astrocytes. However, the increase in gly- 
cogen is not proportional to the increase in C/EBPS or LAP. This 
is not surprising, because it is well known that transient transfec- 
tion of expression vectors causes a small percentage of produc- 
tively transfected cells. For instance, the transfection of hepatoma 
(HepG2) cells with the expression vector MSV-C/EBPa leads to 
the appearance of C/EBPa overexpression in only 1% of the cells 
(Friedman et al., 1989). This observation also applies to the 
mouse primary cultures of astrocytes transfected with MSV-C/ 
EBPS or MSV-LAP, because we observed by immunocytochem- 
istry only a small percentage (3-50/o) of cells expressing high levels 
of CIEBPS or LAP (data not shown). Therefore, the increase in 
glycogen levels in productively transfected astrocytes would be 
reflected only marginally in total glycogen levels. Moreover, 
C/EBPS and LAP likely are not the only limiting transcription 
factors of glycogen synthesis, and their overproduction cannot 
increase glycogen levels proportionally if the other limiting factors 
are not expressed to the same extent as C/EBPS or LAP. One such 
transcription factor could be activator protein-l, because the c$is 
gene is induced by VIP or NA in cultured astrocytes (Arcnander 
et al., 1989; Martin et al., 1992). In view of these considerations, 
the significant increase in glycogen levels after transfection of 
astrocytes with the CIEBPS or LAP expression vector strongly 
supports an involvement of C/EBPp and -6 in the transcriptionally 
regulated CAMP-dependent resynthesis of glycogen evoked by 
VIP and NA. 
Which could be the target genes of C/EBP isoforms, the induc- 
tion of which would lead to an increase in glycogen levels? A 
number of enzymes are potential candidates for such regulation. 
For example, transcription of the glycogen synthase gene might be 
enhanced by VIP or NA via the activation of c/&l>/3 or c/e/@ 
genes. The glycogen synthase cDNA from mouse astrocytes has 
been cloned recently in our laboratory, and the level of expression 
of its mRNA indeed is increased by VIP or NA (Pellegri ct al., in 
press). The promoter of the glycogen synthase gene has not been 
studied and, therefore, it is not known whether it contains CIEBP- 
binding sites. However, very recently an impaired-energy ho- 
meostasis in C/EBPa knock-out mice has been reported (Wang et 
al., 1995). Of interest, mice homozygous for the targeted deletion 
of the clebpa gene did not store hepatic glycogen and died from 
hypoglycemia within 8 hr after birth. In these mutant mice, the 
amounts of glycogen synthase mRNA were 30-50%’ of normal, 
which strongly suggests that this gene is regulated by C/EBP 
isoforms. Glycogen synthesis could be controlled also by the 
availability of glucose-6-phosphate, which is regulated by the 
sequential activity of the glucose transporter and hexokinase. 
There are several glucose transporters and several isoforms of 
hexokinase. As for glycogen synthase, the promoter of the brain 
isotypes of these proteins has not been studied. However, CiEBP 
might play a role in the transcriptional regulation of these genes, 
because C/EBP-binding sites were observed in the promoter of 
the insulin-responsive glucose transporter gent (Kaestner et al., 
1990) whereas in the liver the dynamics of the pattern of expres- 
sion of C/EBPa mRNA were virtually identical to that of the 
hexokinase IV (glucokinase) mRNA (Moorman et al., 1991). It is 
conceivable, therefore, that VIP or NA, by inducing C/EBPp and 
-6 in mouse cortical astrocytes, increases the transcription of the 
glucose transporter and/or the hexokinase genes, leading to a 
stimulation of glycogen synthesis. 
In addition to the involvement of C/EBP isoforms in the glyco- 
gen resynthesis elicited by VIP or NA, this study provides evi- 
dence that neurotransmitters can influence gene transcription in 
astrocytes, therefore demonstrating yet another level of regulation 
in neuron-glia interactions. Moreover, as noted in the introduc- 
tory remarks, the C/EBP transcription factor family plays several 
well documented roles in peripheral tissue, which provide useful 
clues to define the functions of these transcription factors in the 
CNS. 
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